Senna And Docusate Sodium
Product Images NDC 11534-134

1 FDA label image from Sunrise Pharmaceutical Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Senna And Docusate Sodium (NDC 11534-134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sunrise Pharmaceutical Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

D08a4708-figure-01 (D08a4708 Figure 01)

D08a4708-figure-01 (D08a4708 Figure 01)
Senna 8.6 mg and Docusate Sodium 50 mg tablets packaging label from Sunrise Pharmaceutical Inc. It contains 60 tablets and is identified as a stool softener and stimulant laxative. The label includes Drug Facts such as active ingredients, purpose, uses, warnings, directions, and other product information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.